Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Аll
2023
2022
2021
2020
2019
2018
2017
21.04.2023
Pharmasyntez is a partner of the International Student Festival “GxP–Fest 2023”
Read more
14.04.2023
ChemRar and Pharmasyntez have signed a license agreement for the development of an innovative anti-flu drug
Read more
11.04.2023
Pharmasyntez in ratings under 2022 results
Read more
28.03.2023
Representatives of the Healthy Life Forum Official Delegations Visited Pharmasyntez-Nord
Read more
23.03.2023
Pharmasyntez-Nord supported the creating of the VYZOV youth community
Read more
22.03.2023
Natalia Popova, First Deputy General Director of Innopraktika company visited Pharmasyntez-Nord
Read more
21.03.2023
Pharmasyntez-Nord is a partner of the Healthy Life Forum 2023
Read more
18.03.2023
Congratulations on the Anniversary of BratskChemSyntez!
Read more
17.03.2023
Russian industry needs young scientific personnel
Read more
16.03.2023
Pavan Kapoor, Ambassador Extraordinary and Plenipotentiary of the Republic of India to the Russian Federation, visited the Pharmasyntez plant in Irkutsk
Read more
15.03.2023
Congratulations on the Anniversary of Vikram Punia!
Read more
01.03.2023
Tamara Rondalyova: “We can see, what a unique enterprise Pharmasyntez-Nord has built."
Read more
16.02.2023
Congratulations on the Birthday of Pharmasyntez-Tyumen!
Read more
15.02.2023
Pharmasyntez is in the top 10 of the pharmaceutical companies in the state segment now
Read more
04.02.2023
World Cancer Day
Read more
02.02.2023
Winners of “Leaders of Russia” competition visited Pharmasyntez JSC
Read more
News:
← предыдущая
1
2
3
4
5
следующая →
About
History
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
COVID-19
Endocrinology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
Multiple sclerosis
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez